DRESIS
DRESIS provides a comprehensive database of drug resistance information across diverse diseases, cataloging molecular mechanisms and clinically and experimentally verified resistance data to inform research and clinical practice.
Key Features:
- Comprehensive Coverage: DRESIS systematically catalogs all known molecular mechanisms underlying drug resistance, organized into six distinct mechanism types.
- Extensive Disease Range: DRESIS covers a broad range of diseases affected by drug resistance, extending beyond cancers and infections.
- Clinically and Experimentally Verified Data: DRESIS describes clinically and experimentally verified resistance data for a large number of drugs.
Scientific Applications:
- Drug Discovery: Provides detailed resistance landscapes to aid identification of potential targets for new therapeutic interventions.
- Clinical Treatment Optimization: Supplies clinically and experimentally verified resistance data to support tailoring of treatments and addressing resistance in patient care.
- Comparative Disease Analysis: Enables study and comparison of drug resistance mechanisms across a wide range of diseases beyond traditional focuses.
Methodology:
Systematic cataloging and annotation of molecular mechanisms and clinically and experimentally verified drug resistance data.
Topics
Details
- Cost:
- Free of charge
- Tool Type:
- web application
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 1/9/2023
- Last Updated:
- 11/24/2024
Operations
Publications
Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Research. 2022;51(D1):D1263-D1275. doi:10.1093/nar/gkac812. PMID:36243960. PMCID:PMC9825618.
DOI: 10.1093/nar/gkac812
PMID: 36243960
PMCID: PMC9825618
Funding: - Natural Science Foundation of Zhejiang Province: LR21H300001
- National Natural Science Foundation of China: 81872798, U1909208
- Fundamental Research Fund of Central University: 2018QNA7023
- Key R&D Program of Zhejiang Province: 2020C03010
- Chinese ‘Double Top-Class’ Universities: 181201*194232101